T H E O H I O S T A T E U N I V E R S I T Y M E D I C A L C E N T E R

The Ohio State University’s Second Annual Valve and Structural Heart Disease Conference: Transcatheter Management of Aortic Valve Disease

Sponsored by:The Ohio State University Wexner Medical Center in cooperation with The Ohio State University Heart and Vascular Center and the Divisions of Cardiac Surgery and Cardiovascular Medicine

Friday, May 16, 2014

The Ohio State University’s Ohio Union1739 N. High StreetColumbus, Ohio 43210

The Ohio State University’s Second Annual Valve and Structural Heart Disease Conference: Transcatheter Management of Aortic Valve Disease

Target Audience:

Cardiovascular Surgeons, Cardiologists, Primary Care Physicians and Nurses

This one-day symposium will familiarize the Cardiovascular Surgeon, Cardiologist, Primary Care Physician and Nurse with new state-of-the-art-catheter-based therapies for the treatment of senile degenerative cal-cifi c aortic valve stenosis. Following completion of this course, the partici-pant will clearly understand who are candidates for this revolutionary new treatment modality for valvular heart disease. A live case presentation of a valve implant will illustrate the technical aspects of the procedure as well as the potential pitfalls and advantages of new catheter-based valve therapies.

AT THE CONCLUSION OF THIS ACTIVITY PARTICIPANTS SHOULD BE ABLE TO:

1. Identify the current treatment options for patients with severe aorticstenosis.

2. Review patient selection process for transcatheter aortic valve re-placement (TAVR).

3. Describe the outcome data relating to the safety and effi cacy oftranscatheter aortic valve replacement.

COURSE AGENDA

Friday, May 16, 2014

7:00 a.m.

7:30 a.m.

Registration/Breakfast/Visit Exhibits

Introduction

7:45 a.m.

8:00 a.m.

8:35 a.m.

9:10 a.m.

9:30 a.m.

9:45 a.m.

10:05 a.m.

10:25 a.m.

10:55 a.m.

11:15 a.m.

11:30a.m.

Juan Crestanello, MD and Barry George, MD

What is Aortic Stenosis and Why Should We Treat It?

Barry George, MD

CoreValve 2014: State of the Art - What do We Now

Know? Jeffrey Popma, MD

Surgery for Aortic Stenosis - Does it Have a Bright Future?

Hartzell Schaff, MD

Discussion Jeffrey Popma, MD, Hartzell Schaff, MD and

Juan Crestanello, MD, Moderator

Break

Role of Echo and CT in TAVR: You Can’t Hit What You

Can’t See David Orsinelli, MD

AS and Coronary Disease: Old School vs. New School?

Juan Crestanello, MD

Cardiogenic Shock and AS: 4th & Goal, Time Running

Out! Ernest Mazzaferri, Jr., MD

We Can Do TAVR, But Should We?

Ellin Gafford,MD

Break/Lunch

Live Case/Lunch Break

John Cheatham, MD, Moderator

COURSE AGENDA (continued)

12:30 p.m. Break/Return to Main Session

12:45 p.m. Mitral Valve Surgeryand CHallenges of New Technologies: Minimally Invasive, Robotics, Mitra ClipHartzell Schaff, MD

1:30 p.m. Methods of Risk Stratifi cation in AS: Who Should You Ship Out?Scott Lilly, MD, PhD

1:50 p.m. Alternative Access Approaches in TAVR: How do You Get There From Here?Ahmet Kilic, MD

2:10 p.m. Interactive Case Review: The Ohio State University’s Structural Heart Team: Panel Discussion - Did You Learn Anything?Vincent Pompili, MD, Moderator

2:40 p.m. Beyond TAVR: The Future of Structural Heart Dean Boudoulas, MD

3:15 p.m. Adjournment to Reception

THE OHIO STATE UNIVERSITY FACULTY

Konstantinos Dean Boudoulas, MDAssistant Professor of Internal MedicineDivision of Cardiovascular Medicine

John Cheatham, MDProfessor of Pediatrics and Internal Medicine, The Ohio State University Wexner Medical CenterGeorge H. Dunlop Endowed Chair in Interventional CardiologyDirector of Cardiac Catheterization and Interventional TherapyCo-Director, The Heart Center of Nationwide Children’s Hospital

Juan Crestanello, MD*Co-Course DirectorVice Chief of Clinical and Academic Affairs, Division of Cardiac SurgeryAssociate Professor of SurgeryDivision of Cardiac Surgery

Ellin Gafford, MDAssistant Professor of General of Internal MedicineDirector, Division of Palliative Medicine

Barry George, MD*Co-Course DirectorDirector of Advanced Cardiovascular Catheter-Based Therapies and Structural Heart DiseaseAssistant Professor of Internal MedicineDivision of Cardiovascular Medicine

Ahmet Kilic, MDAssistant Professor of SurgeryDivision of Cardiac Surgery

Scott Lilly, MD, PhDAssistant Professor of Internal MedicineDivision of Cardiovascular Medicine

*Members of the planning committee

Ernest Mazzaferri, Jr., MDAssociate Professor of Internal MedicineDivision of Cardiovascular MedicineMedical Director, Ross Heart HospitalThe Ohio State University Wexner Medical Center

David Orsinelli, MDProfessor of Internal MedicineDivision of Cardiovascular Medicine

Vincent J. Pompili, MDProfessor of Internal MedicineDirector of Interventional Cardiovascular Medicine & Cardiac Catheterization LaboratoriesDirector, Cardiovascular Cell-Based Therapies

GUEST FACULTY

Jeffrey Popma, MDDirector, Innovations in Interventional CardiologySenior Attending Physician, Beth Israel Deaconess Medical CenterAssociate Professor of MedicineHarvard Medical SchoolBoston, MA

Hartzell Schaff, MDProfessor of SurgeryDepartment of Cardiovascular SurgeryDepartment of Pediatric and Adolescent MedicineMayo Clinic College of MedicineRochester, MN

*Members of the planning committee

Accreditation Statement: The Ohio State University Wexner Medical Center, Center for Continuing Medi-cal Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

AMA Credit Designation Statement: The Ohio State University Wexner Medical Center designates this educational activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity.

REGISTRATION FORM

To register, visit www.ccme.osu.edu/cmeactivities/courses or mail your completed registration form to: The Ohio State University Wexner Medical CenterDivision of Cardiac SurgeryN825 Doan Hall, Attention: Jonda Thomas410 W. 10th AvenueColumbus, Ohio 43210

If you have any questions, please email ellen.yokoyama@osumc.edu

Program fees include attendance to entire program, course syllabus, course materials and breaks/meals.

q Physician $150 q Nurses and Allied Health Professionals $100q Ohio State University Faculty, Staff and Students $0

FIRST NAME:__________________ LAST NAME:________________________ CREDENTIALS: MD DO PhD PA NP RN LPN EMT Other: _____________ SPECIALTY: _____________________________________________________ ADDRESS 1: _____________________________________________________ ADDRESS 2: _____________________________________________________ CITY: ___________________________ STATE/ZIP: ______________________ PHONE: _____________________________ FAX: _______________________ EMAIL: __________________________________________________________

*Due to information security protocol, we cannot accept faxed registrations containing credit card information.

TYPE OF CARD: q Visa q MasterCard q American Express NAME ON CARD: _________________________________________________ CARD NUMBER: _______________________________ EXP. DATE: ________ SIGNATURE: _______________________________ DATE: _____________

Course Cancelation Policy: Requests for cancelation must be submitted in writing and postmarked on or before 5 p.m. EDT, Friday, May 9, 2014 The Ohio State University Medical Center reserves the right to cancel this program at any time and will assume no fi nancial obligation to the registrants in event of cancellation.

The

Ohi

o S

tate

Uni

vers

ity’s

Sec

ond

Ann

ual V

alve

an

d S

truct

ural

Hea

rt D

isea

se C

onfe

renc

e:

Tran

scat

hete

r Man

agem

ent o

f Aor

tic V

alve

Dis

ease

THE

OH

IO S

TATE

UN

IVE

RS

ITY

HE

AR

T A

ND

VA

SC

ULA

R C

EN

TER

P

O B

ox 1

8310

1C

olum

bus,

OH

432

18,3

101

Frid

ay, M

ay 1

6, 2

014

The

Ohi

o S

tate

Uni

vers

ity’s

Ohi

o U

nion

1739

N. H

igh

Stre

etC

olum

bus,

Ohi

o 43

210

Pre

sort

Firs

t Cla

ssU

.S. P

osta

gePA

IDC

olum

bus,

OH

Per

mit

No.

711